Role of NGAL in Vitiligo

Not Applicable

• Conditions: Vitiligo
• Interventions: Diagnostic Test: NGAL

• Registration Number: NCT05290077
• Lead Sponsor: Sohag University

Brief Summary

Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-07
• Status Verified: 2021-12
• Study First Submitted QC: 2022-03-21
• Study First Posted: 2022-03-22
• Last Update Submitted: 2022-10-28
• Last Update Posted: 2022-10-31
• Study Start: 2022-12-15
• Primary Completion: 2022-12-15
• Study Completion: 2022-12-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• patients with vitiligo above 20y

Exclusion Criteria

• patients with systemic disease Pregnants female Lactating females Patients less than 20 y Patients with active lesions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
control group	NGAL	healthy group
Cases	NGAL	group of vitiligo patients

Primary Outcome Measures

Name	Time	Method
serum Neutrophil Gelatinase-associated Lipocalin in patients with Vitilig	6 months	Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo

Trial Locations

Locations (1)

Sohag fuculty; 🇪🇬 Sohag, Egypt